Published in Parasite Immunol on September 01, 2009
A Functional Role for Antibodies in Tuberculosis. Cell (2016) 2.17
A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One (2013) 1.18
The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett (2010) 1.11
Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies. Infect Immun (2009) 0.91
The spleen CD4+ T cell response to blood-stage Plasmodium chabaudi malaria develops in two phases characterized by different properties. PLoS One (2011) 0.86
T cell responses induced by adenoviral vectored vaccines can be adjuvanted by fusion of antigen to the oligomerization domain of C4b-binding protein. PLoS One (2012) 0.86
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol (2010) 0.85
Assessment of antibody-dependent respiratory burst activity from mouse neutrophils on Plasmodium yoelii malaria challenge outcome. J Leukoc Biol (2013) 0.84
Platelet power: sticky problems for sticky parasites? Trends Parasitol (2009) 0.80
Optimized adenovirus-antibody complexes stimulate strong cellular and humoral immune responses against an encoded antigen in naive mice and those with preexisting immunity. Clin Vaccine Immunol (2011) 0.79
When is a malaria immune complex not an immune complex? Parasite Immunol (2009) 0.79
The genetic control of immunity to Plasmodium infection. BMC Immunol (2015) 0.78
Immunoregulatory functions of immune complexes in vaccine and therapy. EMBO Mol Med (2016) 0.77
B-cells get the T-cells but antibodies get the worms. Trends Parasitol (2009) 0.76
Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge. PLoS One (2016) 0.75
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax. Vaccines (Basel) (2017) 0.75
Fcgamma receptors as regulators of immune responses. Nat Rev Immunol (2008) 11.34
Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science (2005) 6.48
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med (1990) 5.04
Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science (2007) 4.52
FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity (2005) 4.22
Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood (2008) 4.10
Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. J Exp Med (1995) 3.36
Antitumor monoclonal antibodies enhance cross-presentation ofcCellular antigens and the generation of myeloma-specific killer T cells by dendritic cells. J Exp Med (2002) 3.12
The binding site for C1q on IgG. Nature (1988) 3.03
Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J Exp Med (1994) 2.94
Does malaria suffer from lack of memory? Immunol Rev (2004) 2.66
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66
Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity (2005) 2.57
Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med (2002) 2.54
MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol (2001) 2.33
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31
Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci U S A (2005) 2.22
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest (2005) 2.10
Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 2.03
Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature (2008) 1.88
Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. J Mol Biol (2001) 1.87
Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci U S A (2008) 1.82
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med (2003) 1.75
FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity (2002) 1.72
The importance of human FcgammaRI in mediating protection to malaria. PLoS Pathog (2007) 1.61
A novel antibody-dependent cellular cytotoxicity mechanism involved in defense against malaria requires costimulation of monocytes FcgammaRII and FcgammaRIII. J Immunol (2007) 1.61
Computational prediction of host-pathogen protein-protein interactions. Bioinformatics (2007) 1.56
Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc Natl Acad Sci U S A (2007) 1.55
Localisation of the monocyte-binding region on human immunoglobulin G. Mol Immunol (1986) 1.52
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
Structure, organization, and regulation of the complement genes. Annu Rev Immunol (1988) 1.47
Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol (1998) 1.45
Inhibitory pathways triggered by ITIM-containing receptors. Adv Immunol (1999) 1.44
The human monocyte-like cell line THP-1 expresses Fc gamma RI and Fc gamma RII. J Leukoc Biol (1991) 1.40
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria. J Exp Med (2008) 1.38
Identification of a polyclonal B-cell activator in Plasmodium falciparum. Infect Immun (2004) 1.36
Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89. J Biol Chem (2000) 1.29
IgEb immune complexes activate macrophages through FcgammaRIV binding. Nat Immunol (2007) 1.27
Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J Immunol (1998) 1.27
Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med (1998) 1.24
Association of Fcgamma receptor IIa (CD32) polymorphism with severe malaria in West Africa. Am J Trop Med Hyg (2003) 1.24
Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med (2006) 1.21
Human IgG2 can form covalent dimers. J Immunol (2003) 1.21
Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol (2006) 1.19
Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect Immun (1992) 1.18
Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect Immun (2007) 1.17
A critical role of Fc receptor-mediated antibody-dependent phagocytosis in the host resistance to blood-stage Plasmodium berghei XAT infection. J Immunol (2001) 1.16
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). J Immunol (2008) 1.12
Fc receptors and immunity to parasites. Trends Parasitol (2001) 1.11
Inhibitory ITAMs: a matter of life and death. Trends Immunol (2008) 1.10
Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC. Nature (1987) 1.10
How antibodies act as natural adjuvants. Immunol Lett (2005) 1.09
Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia. Infect Immun (1998) 1.08
Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett (2005) 1.08
Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fc gamma receptor ligation in murine macrophages. J Immunol (2007) 1.07
Association between SLE nephritis and polymorphic variants of the CRP and FcgammaRIIIa genes. Rheumatology (Oxford) (2007) 1.06
Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. Eur J Immunol (2008) 1.06
Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection. Blood (2003) 1.05
Enhanced defense against Pneumocystis carinii mediated by a novel dectin-1 receptor Fc fusion protein. J Immunol (2007) 1.00
Targeting weak antigens to CD64 elicits potent humoral responses in human CD64 transgenic mice. J Immunol (2000) 1.00
The IgG-subclass distribution of naturally acquired antibodies to Plasmodium falciparum, in relation to malaria exposure and severity. Ann Trop Med Parasitol (1998) 0.99
Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection. Parasite Immunol (2005) 0.97
Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors. Infect Immun (2000) 0.97
Unusual biochemical features and follicular dendritic cell expression of human Fcalpha/mu receptor. Eur J Immunol (2007) 0.97
CD300 antigen like family member G: A novel Ig receptor like protein exclusively expressed on capillary endothelium. Biochem Biophys Res Commun (2006) 0.95
Complement contributes to protective immunity against reinfection by Plasmodium chabaudi chabaudi parasites. Infect Immun (2001) 0.94
Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor. Eur J Immunol (2009) 0.93
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma. Blood (2000) 0.92
Opinion: antibody-based therapies for malaria. Nat Rev Microbiol (2005) 0.91
Humanisation of monoclonal antibodies for therapy. Semin Immunol (1990) 0.90
Direct interaction between FcgammaRI (CD64) and periplakin controls receptor endocytosis and ligand binding capacity. Proc Natl Acad Sci U S A (2004) 0.90
Antibody- and Fc-receptor-based therapeutics for malaria. Clin Sci (Lond) (2006) 0.85
Immunology. Considering therapeutic antibodies. Science (2006) 0.85
A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors. Eur J Immunol (2007) 0.84
A common theme in interaction of bacterial immunoglobulin-binding proteins with immunoglobulins illustrated in the equine system. J Biol Chem (2008) 0.84
Allotypic markers. Monogr Allergy (1986) 0.79
When is a malaria immune complex not an immune complex? Parasite Immunol (2009) 0.79
Identification of anti-Plasmodium falciparum antibodies in human breast milk. Scand J Immunol Suppl (1992) 0.79
Malaria vaccines: immunity, models and monoclonal antibodies. Trends Parasitol (2008) 0.77
Co-ligation of ICAM-1 (CD54) and membrane IgM negatively affects B cell receptor signaling. Eur J Immunol (1995) 0.76